RauMed Healthcare Technologies

The infrastructure partner for healthcare AI in Türkiye.

We help global healthcare AI companies enter, integrate, validate and scale in one of the region's largest healthcare markets.

Regulatory Technology Clinical Access Commercialization Reimbursement One local partner.
40+
Years in Healthcare
15+
Years in AI & Software
1,000+
Hospitals in Network
Enter the Turkish Market → Explore Our Infrastructure →
Turkish healthcare Where global AI has to actually work
85M+ people under universal coverage
6 layers of market access
Scroll
Experience behind RauMed

Organizations served across the founding companies' 40+ years of healthcare and technology experience.

Healthcare experience
Technology experience

These are reference organizations served by RauMed's founding companies — Bilgin Tıp Medikal, Hekimsan Sağlık and Datailor Technology — not RauMed client relationships.

01

I'm a global AI company

Enter Türkiye. Regulation, localization, hospital integration, clinical pilots, commercialization and reimbursement — handled by one local partner.

Enter the Turkish market →
02

I'm a healthcare organization

Deploy global AI. Technology selection, validation, integration, procurement, deployment and local support — with technologies proven abroad and vetted for Türkiye.

Explore our clinical network →
The problem

Healthcare doesn't globalize like software.

A model can cross borders instantly. Healthcare cannot. Regulation, clinical workflows, data infrastructure, hospital integration and reimbursement remain deeply local.

Local regulation
Medical-device requirements
Health-data rules
Hospital integration
Clinical validation
Procurement
Reimbursement

RauMed provides the local infrastructure between global AI and Turkish healthcare.

The solution

One partner. Six layers of market access.

RauMed is not a consultancy that writes you a report. We build the missing parts of your Turkish operation.

Input Global healthcare AI
Infrastructure RauMed
Output Turkish healthcare market
01

Regulatory & Compliance

  • Türkiye medical-device / SaMD pathway
  • Ministry of Health requirements
  • ÜTS registration support
  • KVKK & health-data compliance
  • Local authorised representation
02

Localization

  • Turkish clinical workflows
  • Language & interface adaptation
  • Clinical terminology alignment
  • Documentation & training material
03

Technology & Integration

  • Hospital information systems
  • PACS / RIS / HIS / LIS
  • APIs & interoperability (HL7, DICOM, FHIR)
  • Cloud & on-prem deployment
  • Cybersecurity & data infrastructure
04

Clinical Validation & Adoption

  • Pilot hospitals
  • KOL network
  • Clinical validation studies
  • Physician onboarding
  • Real-world evidence
05

Market Access & Commercialization

  • Public & private hospital channels
  • Sales infrastructure
  • Tender & procurement support
  • Distribution
  • Local technical & customer support
06

Reimbursement

  • SGK pathway analysis
  • Health economics & outcomes
  • Reimbursement strategy
  • Commercial model design
Why RauMed

Two proven infrastructures, joined into one.

RauMed's story is less about a new company than about two separate capabilities finally meeting.

40+
years healthcare infrastructure
+
15+
years technology infrastructure
+
1,000+
hospitals in reach
=
One health AI market-access platform
Founding infrastructure

Built on two proven infrastructures.

RauMed did not start from zero.

Bilgin Tıp Medikal & Hekimsan Sağlık

35+ years of healthcare market access: medical-device distribution, hospital and surgeon networks, tender and procurement operations, reimbursement experience, nationwide clinical relationships.

Datailor Technology

15+ years of software engineering, artificial intelligence, data systems and enterprise integration — production systems for regulated industries, not demos.

RauMed Healthcare Technologies

Healthcare AI market-access infrastructure for Türkiye.

How we work together

Flexible partnership models.

Every technology enters a market differently. We structure the relationship around where you are.

01

Exclusive Türkiye Partnership

Single local partner for the entire Turkish market.

02

Distribution & Commercialization

Sales, tenders, delivery and local customer support.

03

Regulatory Representation

Local authorised representative, registration and compliance.

04

Clinical Pilot & Validation

Pilot hospitals, KOLs and real-world evidence generation.

05

Technology Integration

PACS/HIS integration, deployment, data and security work.

06

Joint Venture

A shared local entity for long-term market commitment.

07

Regional Expansion

Once Türkiye works, the same playbook extends outward.

See partnership details →
Technologies we partner with

Seven frontiers of clinical AI.

These are the categories where we take technologies into the Turkish market.

01
AI Diagnostics
From imaging to molecular.
02
Predictive Healthcare
Risk models on real-world data.
03
Digital Surgery
Computer-vision & robotics.
04
Oncology AI
Multimodal cancer intelligence.
05
Radiology AI
The most mature AI vertical.
06
Wound Care Technologies
Imaging, prediction, healing.
07
Clinical Decision Intelligence
From data to bedside action.
+
Continuously expanding
As the field grows, we grow with it.
Why Türkiye

A large healthcare market — but not a plug-and-play one.

Türkiye combines the scale of a major healthcare system with the complexity of a tightly regulated one.

85M+
population
Universal
health coverage through SGK
1,500+
public & private hospitals
High
medical-device & imaging utilization
Regional gateway
strategic access to MENA, the Balkans, the Caucasus and Central Asia

A large healthcare market — but not a plug-and-play market.

That's where RauMed comes in. Türkiye first. Regional next.
RauMed Health AI Intelligence

We map the global landscape to find what's ready for the clinic.

We continuously map the global healthcare AI landscape to identify technologies ready for regulated clinical deployment.

FDA Clearance

Aidoc's CARE1™ — first foundation-model clinical AI cleared

In February 2025, the FDA cleared Aidoc's CARE1 — the first foundation-model-powered clinical AI to receive U.S. authorization.

Radiology · Foundation Model Feb 2025
Breakthrough Device

Paige's PanCancer Detect named FDA Breakthrough

April 2025: Paige received FDA Breakthrough Device designation for PanCancer Detect — the first AI tool to identify both common and rare cancer variants across multiple tissue types.

Digital Pathology · Oncology Apr 2025
Clinical Validation

Viz.ai cuts stroke evaluation time by ~66 minutes

ISC 2025 evidence: in 1,600+ hospitals, Viz.ai's LVO triage shortens CT-to-EVT timing and re-routes patients faster.

Neuro · Stroke AI 2025
See the full intelligence feed →
The market

Numbers behind the moment.

FDA AI-enabled medical device authorizations have crossed 1,450. Almost none of them are commercially available in Türkiye yet.

1,451+
FDA AI-enabled devices (cumulative, end 2025)
76%
of all AI clearances are radiology
295
new AI authorizations in 2025
31hr
One AI SaMD clearance every 31 hours (Mar 2026)
Your AI is global. Healthcare is local.

We bridge the two.

Bring your healthcare AI technology to Türkiye — with the partner that already holds the regulatory, clinical, technical and commercial infrastructure.

Talk to RauMed →